Concepedia

David I. Ortiz-Melo

DI

Statistics

Publications

7

Citations

902

H-Index

7

Active since

2012

Affiliations

University of Miami(Current)

University of California, Los Angeles

Duke University

Brigham and Women's Hospital

University of Toronto

David I. Ortiz-Melo is an author at University of Miami specializing in medicine, oncology, and sodium homeostasis.

ORCID

Top concepts

Publications per year

2012–2022

7

Publications

7

Clinical Features and Outcomes of Immune Checkpoint Inhibitor–Associated AKI: A Multicenter Study

Frank B. Cortazar, Zoé A. Kibbelaar, Ilya Glezerman et al. · Journal of the American Society of Nephrology · 2020 · 370 citations · Full text

Acute kidney injury in patients treated with immune checkpoint inhibitors

Shruti Gupta, Samuel Short, Meghan E. Sise et al. · Journal for ImmunoTherapy of Cancer · 2021 · 213 citations · Full text

A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant

Naoka Murakami, Patrick M. Mulvaney, Melissa Danesh et al. · Kidney International · 2020 · 168 citations · Full text

, , +11

ACE2 deficiency increases NADPH-mediated oxidative stress in the kidney

Jan Wysocki, David I. Ortiz-Melo, Natalie K Mattocks et al. · Physiological Reports · 2014 · 67 citations · Full text

The Latino Health Project: pilot testing a culturally adapted behavioral weight loss intervention in obese and overweight Latino adults.

Leonor Corsino, María Pilar Rocha-Goldberg, Bryan C. Batch et al. · PubMed · 2012 · 40 citations

1–5 of 7